Cover Image

Pathologic Complete Response Prediction to Neoadjuvant Immunotherapy Combined with Chemotherapy in Resectable Locally Advanced Esophageal Squamous Cell Carcinoma: Real-World Evidence from Integrative Inflammatory and Nutritional Scores

Jifeng Feng,1- 3 Liang Wang,1 Xun Yang,1 Qixun Chen,1 Xiangdong Cheng2 1Department of Thoracic Oncological Surgery, Cancer Hospital of University of Chinese Academy of Sciences, Zhejiang Cancer Hospital, Hangzhou, People's Republic of China; 2Zhejiang Provincial Research Center for Upper Gastro...

Full description

Saved in:

Bibliographic Details
Main Authors:	Feng J (Author), Wang L (Author), Yang X (Author), Chen Q (Author), Cheng X (Author)
Format:	Book
Published:	Dove Medical Press, 2022-07-01T00:00:00Z.
Subjects:	article
Online Access:	Connect to this object online.
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

A Novel Predictor of Pathologic Complete Response for Neoadjuvant Immunochemotherapy in Resectable Locally Advanced Esophageal Squamous Cell Carcinoma
by: Yang Y, et al.
Published: (2023)

Comparison of Neoadjuvant Immunotherapy Plus Chemotherapy versus Neoadjuvant Chemoradiotherapy for Patients with Esophageal Squamous Cell Carcinoma: A Propensity Score Matching Study
by: Zhao J, et al.
Published: (2023)

Functional heterogeneity of cancer-associated fibroblasts with distinct neoadjuvant immunotherapy plus chemotherapy response in esophageal squamous cell carcinoma
by: Jun Jiang, et al.
Published: (2024)

Naples Prognostic Score as an Independent Predictor of Survival Outcomes for Resected Locally Advanced Non-Small Cell Lung Cancer Patients After Neoadjuvant Treatment
by: Zou Z, et al.
Published: (2023)

Accuracy of core biopsy image-guided post-neoadjuvant chemotherapy breast to predict pathologic complete response
by: P. V. Krivorotko, et al.
Published: (2022)

Clinical Implications of Naples Prognostic Score for Patients with Resected Cholangiocarcinoma: A Real-World Experience
by: Xu B, et al.
Published: (2024)

Evaluation of the Efficacy of Neoadjuvant Chemotherapy for Breast Cancer
by: Wang H, et al.
Published: (2020)

Evidence for the evolving role of neoadjuvant and perioperative immunotherapy in resectable non-small cell lung cancer
by: Thomas Hansen, et al.
Published: (2024)

Case Report: Pathological Complete Response to Neoadjuvant Alectinib in a Patient With Resectable ALK-Positive Non-Small Cell Lung Cancer
by: Yan Hu, et al.
Published: (2022)

Neoadjuvant Chemotherapy in Early Triple-Negative Breast Cancer: A Pairwise and Network Meta-Analysis of Pathological Complete Response
by: Zeng-Jie Weng MM, et al.
Published: (2021)

Complete pathological remission and tertiary lymphoid structures are associated with the efficacy of resectable NSCLC receiving neoadjuvant chemoimmunotherapy: A double-center retrospective study
by: Ying Liu, et al.
Published: (2023)

The Systemic Immune-Inflammation Index as an Independent Predictor of Survival in Patients with Locally Advanced Esophageal Squamous Cell Carcinoma Undergoing Neoadjuvant Radiotherapy
by: Zhang H, et al.
Published: (2024)

Evaluation of survival and recurrence patterns in esophageal cancer patients with pathological response to neoadjuvant chemoradiotherapy
by: Ali Kermani, et al.
Published: (2020)

Post-neoadjuvant chemoradiotherapy tumor resectability following induction chemotherapy in locally advanced proximal gastric and adenocarcinoma of the esophagogastric junction: A clinical trial
by: Seyed Amir Aledavood, et al.
Published: (2021)

Gastric cancer immune microenvironment score predicts neoadjuvant chemotherapy efficacy and prognosis
by: Shaoji Zhao, et al.
Published: (2024)

THE ESTIMATION OF EFFICIENCY OF NEOADJUVANT CHEMOTHERAPY IN PATIENTS WITH LOCALLY ADVANCED OVARIAN CANCER
by: T. Tarasenko, et al.
Published: (2015)

Correlation of the value of sonoelastography strain ratio with the degree of pathological regression in patients with locally advanced breast cancer undergoing neoadjuvant chemotherapy
by: E. A. Bus'ko, et al.
Published: (2017)

Real-world data on adjuvant capecitabine after standard neoadjuvant chemotherapy for triple negative breast cancer
by: Maria Fernanda Imperio Pereira, et al.
Published: (2024)

Surveillance for metachronous cancers after endoscopic resection of esophageal squamous cell carcinoma
by: Ryu Ishihara
Published: (2024)

Tertiary lymphoid structures favor outcome in resected esophageal squamous cell carcinoma
by: Rutao Li, et al.
Published: (2022)

Estrogen receptor-negative/progesterone receptor-positive breast cancer has distinct characteristics and pathologic complete response rate after neoadjuvant chemotherapy
by: He Dou, et al.
Published: (2024)

Cost-Effectiveness of Nivolumab Immunotherapy vs. Paclitaxel or Docetaxel Chemotherapy as Second-Line Therapy in Advanced Esophageal Squamous Cell Carcinoma in China
by: Ying-tao Lin, et al.
Published: (2022)

Neoadjuvant Chemotherapy Current Applications in Clinical Practice
Published: (2012)

Neoadjuvant Chemotherapy Increasing Relevance in Cancer Management
Published: (2013)

Neutrophil-to-lymphocyte ratio and chemotherapy response score as prognostic markers in ovarian cancer patients treated with neoadjuvant chemotherapy
by: M. Liontos, et al.
Published: (2021)

Tailoring neoadjuvant chemotherapy for a pregnant patient diagnosed with IB2 squamous cervical carcinoma
by: Anna Babkova, et al.
Published: (2024)

LncRNA Profile Study Reveals a Three-LncRNA Signature Associated With the Pathological Complete Response Following Neoadjuvant Chemotherapy in Breast Cancer
by: Ying Zeng, et al.
Published: (2019)

Evaluation of Pathologic Complete Response in Breast Cancer Patients Treated with Neoadjuvant Chemotherapy: Experience in a Single Institution over a 10-Year Period
by: Misun Choi, et al.
Published: (2017)

Strategies for the Endoscopic Management and Post-Resection Treatment of Superficial Esophageal Squamous Cell Carcinoma
by: Hyun Ho Choi
Published: (2024)

Timing of interval debulking surgery and postoperative chemotherapy after neoadjuvant chemotherapy in advanced epithelial ovarian cancer: a multicenter real-world study
by: Xingyu Liu, et al.
Published: (2023)

Effect of Estrogen Receptor on the Relationship Between HER2 Immunohistochemistry Score and Pathological Complete Response to Neoadjuvant Treatment in HER2-Positive Breast Cancer
by: Miaomiao Jia, et al.
Published: (2024)

The role of neoadjuvant chemotherapy in the management of locally advanced cervix cancer: a systematic review
by: Mohammed Osman
Published: (2014)

The Outcome of Induction Chemotherapy, Followed by Neoadjuvant Chemoradiotherapy and Surgery, in Locally Advanced Rectal Cancer
by: Ali Yaghobi Joybari, et al.
Published: (2021)

Neoadjuvant chemotherapy is associated with worse prognosis in patients with advanced-stage epithelial ovarian cancer: Is it real?
by: Yiu-Tai Li, et al.
Published: (2024)

Pathological complete remission of a locally advanced gastric cancer by neoadjuvant therapy "sandwich" regimen as SOXAP+ fluorescence laparoscopic surgery +SOXAP: Case report
by: Yanling Ma, et al.
Published: (2022)

Neoadjuvant chemotherapy increases the 5-year overall survival of patients with resectable cervical cancer: A systematic review and meta-analysis
by: Yunbao Xu, et al.
Published: (2021)

Disease-free remission of metastatic adrenocortical carcinoma following en bloc tumor resection and neoadjuvant chemotherapy for suspected adrenohepatic infiltration
by: Daniel Pasquale Cinelli, et al.
Published: (2021)

CIC-DUX4 rearranged uterine cervix round-cell sarcoma exhibiting near-complete pathologic response following radiation and neoadjuvant chemotherapy: A case report
by: Aline Cristini Vieira, et al.
Published: (2021)

Prediction of Neoadjuvant Chemoradiotherapy Sensitivity in Patients With Esophageal Squamous Cell Carcinoma Using CT-Based Radiomics Combined With Clinical Features
by: Xindi Li, et al.
Published: (2024)

Cost-Effectiveness Analysis of Tislelizumab Plus Chemotherapy as First-Line Treatment for Advanced or Metastatic Esophageal Squamous Cell Carcinoma in China
by: Zhou C, et al.
Published: (2023)